NANCY MCDOWELL: Open Payments
NPI 1710234398 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,335 in 113 payments from 26 companies in 2025. Trend: 2023 $2,178 · 2024 $2,230 · 2025 $2,335
Food & beverage: $2,335
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $315 |
| Novo Nordisk Inc | 16 | $303 |
| Sumitomo Pharma America, Inc. | 11 | $238 |
| Novartis Pharmaceuticals Corporation | 5 | $194 |
| ABBVIE INC. | 12 | $169 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| SCPHARMACEUTICALS INC. | 5 | $114 |
| GlaxoSmithKline, LLC. | 5 | $104 |
| PFIZER INC. | 5 | $96 |
| Dexcom, Inc. | 5 | $91 |
Products named: GEMTESA, LEQVIO, MOUNJARO, Ozempic, KISUNLA, REXULTI, FUROSCIX, Wegovy.
Industry payments across TX — which companies pay providers there.
